8224 Federal Register / Vol. 89, No. 25 / Tuesday, February 6, 2024 / Notices 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Molecular Atlas of Lung Development 

(LungMAP) Program. 

Date: March 1, 2024. 

Time: 10:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge I, 6705 Rockledge Drive, Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: Kristen Page, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung, and 

Blood Institute, National Institutes of Health, 

6705 Rockledge Drive, Suite 209–B, 

Bethesda, MD 20892, (301) 827–7953, 

kristen.page@nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Early Phase Clinical Trials (R61/R33). 

Date: March 1, 2024. 

Time: 10:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge I, 6705 Rockledge Drive, Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: Manoj K. Valiyaveettil, 

Ph.D., Scientific Review Officer, Blood & 

Vascular Branch, Office Scientific Review, 

Division of Extramural Research Activities 

(DERA), National Institute of Health, 

National Heart, Lung, and Blood Institute, 

Bethesda, MD 20817, (301) 402–1616, 

manoj.valiyaveettil@nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

NHLBI TOPMed: Omics Phenotypes of Heart, 

Lung, and Blood Disorders (X01). 

Date: March 6, 2024. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge I, 6705 Rockledge Drive, Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: Susan Wohler Sunnarborg, 

Ph.D., Scientific Review Officer, Office of 

Scientific Review/DERA, National, Heart, 

Lung, and Blood Institute, National Institutes 

of Health, 6705 Rockledge Drive, Room 208– 

Z, Bethesda, MD 20892, (301) 827–7987, 

susan.sunnarborg@nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Molecular Phenotypes of Asthma 

Exacerbation in Children. 

Date: March 7, 2024. 

Time: 1:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge I, 6705 Rockledge Drive, Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: YingYing Li-Smerin, M.D., 

Ph.D., Scientific Review Officer, Office of 

Scientific Review/DERA, National Heart, 

Lung, and Blood Institute, National Institutes 

of Health, 6705 Rockledge Drive, Room 207– 

P, Bethesda, MD 20892–7924, (301) 827– 

7942, lismerin@nhlbi.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Mentored Career Development Award to 

Promote Faculty Research Diversity. 

Date: March 8, 2024. 

Time: 10:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge I, 6705 Rockledge Drive, Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: Shelley Sehnert, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung, and 

Blood Institute, National Institutes of Health, 

6705 Rockledge Drive, Suite 208–T, 

Bethesda, MD 20817, (301) 827–7984, 

ssehnert@nhlbi.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

The Blood and Marrow Transplant Clinical 

Trials Network—Core Clinical Centers (UG1) 

Review Panel. 

Date: March 11, 2024. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge I, 6705 Rockledge Drive, Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: Kazuyo Kegan, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung, and 

Blood Institute, National Institutes of Health, 

6705 Rockledge Drive, Room 208–T, 

Bethesda, MD 20892, (301) 402–1334, 

kazuyo.kegan@nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

The Blood and Marrow Transplant Clinical 

Trials Network Data Coordinating Center 

(U24) Review Panel. 

Date: March 12, 2024. 

Time: 11:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge I, 6705 Rockledge Drive, Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: Kazuyo Kegan, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung, and 

Blood Institute, National Institutes of Health, 

6705 Rockledge Drive, Room 208–T, 

Bethesda, MD 20892, (301) 402–1334, 

kazuyo.kegan@nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Catalyze Product Definition (R61/R33). 

Date: March 13, 2024. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge I, 6705 Rockledge Drive, Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: Manoj K. Valiyaveettil, 

Ph.D., Scientific Review Officer, Blood & 

Vascular Branch, Office Scientific Review, 

Division of Extramural Research Activities 

(DERA), National Institute of Health, 

National Heart, Lung, and Blood Institute, 

Bethesda, MD 20817, (301) 402–1616, 

manoj.valiyaveettil@nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Clinical Trials SEP (UG3, U24). 

Date: March 14, 2024 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge I, 6705 Rockledge Drive, Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: Zhihong Shan, Ph.D., 

M.D., Scientific Review Officer, Office of 

Scientific Review/DERA, National Heart, 

Lung, and Blood Institute, National Institutes 

of Health, 6705 Rockledge Drive, Room 205– 

J, Bethesda, MD 20892, (301) 827–7085, 

zhihong.shan@nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

NHLBI Biorepository: Scientific 

Opportunities for Exploratory Research 

(R21). 

Date: March 15, 2024. 

Time: 10:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge I, 6705 Rockledge Drive, Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: Sun Saret, Ph.D., Scientific 

Review Officer, Office of Scientific Review/ 

DERA, National Heart, Lung, and Blood 

Institute, National Institutes of Health, 6705 

Rockledge Drive, Room 208–S, Bethesda, MD 

20892, (301) 435–0270 sun.saret@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: February 1, 2024. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–02353 Filed 2–5–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

[Internal Agency Docket No. FEMA–4751– 

DR; Docket ID FEMA–2023–0001] 

Tennessee; Amendment No. 1 to 

Notice of a Major Disaster Declaration 

AGENCY: Federal Emergency 

Management Agency, DHS. 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 25 / Tuesday, February 6, 2024 / Notices 8225 

ACTION: Notice. 

SUMMARY: This notice amends the notice 

of a major disaster declaration for the 

State of Tennessee (FEMA–4751–DR), 

dated December 13, 2023, and related 

determinations. 

DATES: This amendment was issued 

December 28, 2023. 

FOR FURTHER INFORMATION CONTACT: 

Dean Webster, Office of Response and 

Recovery, Federal Emergency 

Management Agency, 500 C Street SW, 

Washington, DC 20472, (202) 646–2833. 

SUPPLEMENTARY INFORMATION: The notice 

of a major disaster declaration for the 

State of Tennessee is hereby amended to 

include the following areas among those 

areas determined to have been adversely 

affected by the event declared a major 

disaster by the President in his 

declaration of December 13, 2023. 

Cheatham, Gibson, and Stewart Counties 

for Individual Assistance. 

The following Catalog of Federal Domestic 

Assistance Numbers (CFDA) are to be used 

for reporting and drawing funds: 97.030, 

Community Disaster Loans; 97.031, Cora 

Brown Fund; 97.032, Crisis Counseling; 

97.033, Disaster Legal Services; 97.034, 

Disaster Unemployment Assistance (DUA); 

97.046, Fire Management Assistance Grant; 

97.048, Disaster Housing Assistance to 

Individuals and Households In Presidentially 

Declared Disaster Areas; 97.049, 

Presidentially Declared Disaster Assistance— 

Disaster Housing Operations for Individuals 

and Households; 97.050 Presidentially 

Declared Disaster Assistance to Individuals 

and Households—Other Needs; 97.036, 

Disaster Grants—Public Assistance 

(Presidentially Declared Disasters); 97.039, 

Hazard Mitigation Grant. 

Deanne Criswell, 

Administrator, Federal Emergency 

Management Agency. 

[FR Doc. 2024–02374 Filed 2–5–24; 8:45 am] 

BILLING CODE 9111–23–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

[Internal Agency Docket No. FEMA–4752– 

DR; Docket ID FEMA–2024–0001] 

Utah; Major Disaster and Related 

Determinations 

AGENCY: Federal Emergency 

Management Agency, DHS. 

ACTION: Notice. 

SUMMARY: This is a notice of the 

Presidential declaration of a major 

disaster for the State of Utah (FEMA– 

4752–DR), dated December 23, 2023, 

and related determinations. 

DATES: The declaration was issued 

December 23, 2023. 

FOR FURTHER INFORMATION CONTACT: 

Dean Webster, Office of Response and 

Recovery, Federal Emergency 

Management Agency, 500 C Street SW, 

Washington, DC 20472, (202) 646–2833. 

SUPPLEMENTARY INFORMATION: Notice is 

hereby given that, in a letter dated 

December 23, 2023, the President issued 

a major disaster declaration under the 

authority of the Robert T. Stafford 

Disaster Relief and Emergency 

Assistance Act, 42 U.S.C. 5121 et seq. 

(the ‘‘Stafford Act’’), as follows: 

I have determined that the damage in 

certain areas of the State of Utah resulting 

from flooding during the period of May 1 to 

May 27, 2023, is of sufficient severity and 

magnitude to warrant a major disaster 

declaration under the Robert T. Stafford 

Disaster Relief and Emergency Assistance 

Act, 42 U.S.C. 5121 et seq. (the ‘‘Stafford 

Act’’). Therefore, I declare that such a major 

disaster exists in the State of Utah. 

In order to provide Federal assistance, you 

are hereby authorized to allocate from funds 

available for these purposes such amounts as 

you find necessary for Federal disaster 

assistance and administrative expenses. 

You are authorized to provide Public 

Assistance in the designated areas and 

Hazard Mitigation throughout the State. 

Consistent with the requirement that Federal 

assistance be supplemental, any Federal 

funds provided under the Stafford Act for 

Public Assistance and Hazard Mitigation will 

be limited to 75 percent of the total eligible 

costs. 

Further, you are authorized to make 

changes to this declaration for the approved 

assistance to the extent allowable under the 

Stafford Act. 

The Federal Emergency Management 

Agency (FEMA) hereby gives notice that 

pursuant to the authority vested in the 

Administrator, under Executive Order 

12148, as amended, Jon K. Huss, of 

FEMA is appointed to act as the Federal 

Coordinating Officer for this major 

disaster. 

The following areas of the State of 

Utah have been designated as adversely 

affected by this major disaster: 

Iron, Morgan, Sanpete, Utah, and Wasatch 

Counties for Public Assistance. 

All areas within the State of Utah are 

eligible for assistance under the Hazard 

Mitigation Grant Program. 

The following Catalog of Federal Domestic 

Assistance Numbers (CFDA) are to be used 

for reporting and drawing funds: 97.030, 

Community Disaster Loans; 97.031, Cora 

Brown Fund; 97.032, Crisis Counseling; 

97.033, Disaster Legal Services; 97.034, 

Disaster Unemployment Assistance (DUA); 

97.046, Fire Management Assistance Grant; 

97.048, Disaster Housing Assistance to 

Individuals and Households In Presidentially 

Declared Disaster Areas; 97.049, 

Presidentially Declared Disaster Assistance— 

Disaster Housing Operations for Individuals 

and Households; 97.050, Presidentially 

Declared Disaster Assistance to Individuals 

and Households—Other Needs; 97.036, 

Disaster Grants—Public Assistance 

(Presidentially Declared Disasters); 97.039, 

Hazard Mitigation Grant. 

Deanne Criswell, 

Administrator, Federal Emergency 

Management Agency. 

[FR Doc. 2024–02376 Filed 2–5–24; 8:45 am] 

BILLING CODE 9111–23–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

[Internal Agency Docket No. FEMA–4539– 

DR; Docket ID FEMA–2024–0001] 

Washington; Amendment No. 6 to 

Notice of a Major Disaster Declaration 

AGENCY: Federal Emergency 

Management Agency, DHS. 

ACTION: Notice. 

SUMMARY: This notice amends the notice 

of a major disaster declaration for the 

State of Washington (FEMA–4539–DR), 

dated April 23, 2020, and related 

determinations. 

DATES: This change occurred on January 

19, 2024. 

FOR FURTHER INFORMATION CONTACT: 

Dean Webster, Office of Response and 

Recovery, Federal Emergency 

Management Agency, 500 C Street SW, 

Washington, DC 20472, (202) 646–2833. 

SUPPLEMENTARY INFORMATION: The 

Federal Emergency Management Agency 

(FEMA) hereby gives notice that 

pursuant to the authority vested in the 

Administrator, under Executive Order 

12148, as amended, Lance E. Davis, of 

FEMA is appointed to act as the Federal 

Coordinating Officer for this disaster. 

This action terminates the 

appointment of Toney L. Raines as 

Federal Coordinating Officer for this 

disaster. 

The following Catalog of Federal Domestic 

Assistance Numbers (CFDA) are to be used 

for reporting and drawing funds: 97.030, 

Community Disaster Loans; 97.031, Cora 

Brown Fund; 97.032, Crisis Counseling; 

97.033, Disaster Legal Services; 97.034, 

Disaster Unemployment Assistance (DUA); 

97.046, Fire Management Assistance Grant; 

97.048, Disaster Housing Assistance to 

Individuals and Households In Presidentially 

Declared Disaster Areas; 97.049, 

Presidentially Declared Disaster Assistance— 

Disaster Housing Operations for Individuals 

and Households; 97.050, Presidentially 

Declared Disaster Assistance to Individuals 

and Households—Other Needs; 97.036, 

Disaster Grants—Public Assistance 


ddrumheller on DSK120RN23PROD with NOTICES1